TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 29727028

Group type: EXPERIMENTAL
Intervention: Deep neuromuscular blockade (post-tetanic count 1-2 maintained and reversed with sugammadex)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Moderate neuromuscular blockade (train-of-four count 1-2 maintained and antagonised with neostigmine)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Deep neuromuscular blockade
Number of subjects: 64

Group type: COMPARATOR
Intervention: Moderate neuromuscular blockade
Number of subjects: 64
Study: 27389114

Group type: EXPERIMENTAL
Intervention: Nervomatrix Soleve® auto‐targeted neurostimulation device providing TENS-stimulation and mechanical pressure
Number of subjects: 39

Group type: COMPARATOR
Intervention: Placebo group (Nervomatrix Soleve® auto‐targeted neurostimulation device providing mechanical pressure alone without current)
Number of subjects: 39
Study: 25009402

Group type: EXPERIMENTAL
Intervention: Proximal gastrectomy with jejunal interposition (PGJI)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Total gastrectomy with Roux-en-Y anastomosis (TGRY)
Number of subjects: 76
Study: 23217501

Group type: EXPERIMENTAL
Intervention: Phytoestrogen supplementation (Bioos, Montegiorgio, Italy)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Placebo tablets
Number of subjects: 66
Study: 20919776

Group type: EXPERIMENTAL
Intervention: High epistemic motivation (mild vs. intense time pressure; presence vs. absence of process accountability)
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Prosocial motives
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Priming of originality norms
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Priming of appropriateness norms
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Epistemic motivation
Number of subjects: 3
Study: 18347893

Group type: EXPERIMENTAL
Intervention: Loss-framed message (one shot)
Number of subjects: 237

Group type: COMPARATOR
Intervention: Gain-framed message (one shot)
Number of subjects: 237

Group type: COMPARATOR
Intervention: Loss-framed message (six shots)
Number of subjects: 237

Group type: COMPARATOR
Intervention: Gain-framed message (six shots)
Number of subjects: 237
Study: 16251559

Group type: EXPERIMENTAL
Intervention: Xenon anesthesia
Number of subjects: 42

Group type: COMPARATOR
Intervention: Propofol anesthesia
Number of subjects: 42
Study: 12788862

Group type: EXPERIMENTAL
Intervention: Flutamide (125 mg/d) and Metformin (1275 mg/d)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control phase (3 months, n = 14)
Number of subjects: 30
Study: 10343482

Group type: EXPERIMENTAL
Intervention: Nurses in CQI teams
Number of subjects: 0
Study: 8951297

Group type: EXPERIMENTAL
Intervention: IV immune globulin treatment
Number of subjects: 127
Study: 29846630

Group type: EXPERIMENTAL
Intervention: Levothyroxine
Number of subjects: 185

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 185
Study: 27911904

Group type: EXPERIMENTAL
Intervention: Dressing removed on the first postoperative day (group I)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Dressing removed on the sixth postoperative day (group II)
Number of subjects: 200
Study: 24863728

Group type: EXPERIMENTAL
Intervention: Ischemic preconditioning (IPC)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Control (CON)
Number of subjects: 15
Study: 23147280

Group type: EXPERIMENTAL
Intervention: Nasoalveolar molding (NAM)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Passive orthopedic method (Hotz plate, HP)
Number of subjects: 28
Study: 21178937

Group type: EXPERIMENTAL
Intervention: Aerobic exercise program (16 weeks, 3 days/week, 90 min, 50‐80% VO2max)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Control group (no exercise)
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Aerobic exercise program
Number of subjects: 65

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 65
Study: 17215848

Group type: COMPARATOR
Intervention: Amlodipine 10 mg
Number of subjects: 80

Group type: COMPARATOR
Intervention: Valsartan 160 mg
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Amlodipine 10 mg plus Valsartan 160 mg
Number of subjects: 80
Study: 15769714

Group type: EXPERIMENTAL
Intervention: 16-slice multislice computed tomographic (MSCT) angiography
Number of subjects: 50
Study: 12132278

Group type: EXPERIMENTAL
Intervention: Basic analgesics combined with on demand medication (group 2)
Number of subjects: 215

Group type: COMPARATOR
Intervention: On demand medication exclusively (group 1)
Number of subjects: 215
Study: 9660994

Group type: EXPERIMENTAL
Intervention: Adefovir dipivoxil (120 mg daily) for 6 months
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Adefovir dipivoxil (120 mg daily) for 12 months
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Adefovir dipivoxil (120 mg daily) with or without concomitant antiretroviral agents
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Adefovir dipivoxil (120 mg daily)
Number of subjects: 29
Study: 7648767

Group type: EXPERIMENTAL
Intervention: Immediate-release formulation of racemic verapamil (240 mg)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Sustained-release formulation of racemic verapamil (240 mg)
Number of subjects: 12
Study: 2668365

Group type: EXPERIMENTAL
Intervention: Sodium fluoride (NaF) dentifrice
Number of subjects: 3290

Group type: COMPARATOR
Intervention: Sodium monofluorophosphate (Na2PO3F) dentifrice
Number of subjects: 3290
Study: 1272739

Group type: EXPERIMENTAL
Intervention: Tone or music stimuli with soft or loud intensities for 5 sec. or 30 sec. adaptation periods.
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Tone or music stimuli with soft or loud intensities for 5 min. adaptation periods.
Number of subjects: 64
Study: 31672070

Group type: EXPERIMENTAL
Intervention: BBTI (Brief Behavioral Treatment for Insomnia)
Number of subjects: 40

Group type: COMPARATOR
Intervention: HEP (Healthy Eating Program)
Number of subjects: 40
Study: 31518644

Group type: EXPERIMENTAL
Intervention: Lenalidomide and Vorinostat
Number of subjects: 16
Study: 28566524

Group type: COMPARATOR
Intervention: Mediterranean Diet (MedDiet)
Number of subjects: 166

Group type: EXPERIMENTAL
Intervention: Habitual Diet (HabDiet)
Number of subjects: 166
Study: 25862517

Group type: EXPERIMENTAL
Intervention: Maintenance treatment with capecitabine and bevacizumab
Number of subjects: 558

Group type: COMPARATOR
Intervention: Observation
Number of subjects: 558
Study: 23123046

Group type: EXPERIMENTAL
Intervention: solution-focused therapy
Number of subjects: 326

Group type: EXPERIMENTAL
Intervention: short-term psychodynamic psychotherapy
Number of subjects: 326

Group type: EXPERIMENTAL
Intervention: long-term psychodynamic psychotherapy
Number of subjects: 326

Group type: COMPARATOR
Intervention: short-term or long-term therapy
Number of subjects: 326
Study: 21372697

Group type: EXPERIMENTAL
Intervention: Nurse-led cognitive-behavior therapy (CBT) for 6 weeks
Number of subjects: 71

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 71
Study: 19921983

Group type: EXPERIMENTAL
Intervention: Dutasteride 5 mg/day for 5 weeks
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Serenoa repens 160 mg/day for 5 weeks
Number of subjects: 75

Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 75
Study: 16432265

Group type: EXPERIMENTAL
Intervention: Ramelteon 4 mg
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Ramelteon 8 mg
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Ramelteon 16 mg
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Ramelteon 32 mg
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Ramelteon 64 mg
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 12973135

Group type: EXPERIMENTAL
Intervention: Percutaneous intradiscal radiofrequency thermocoagulation for 120 seconds at 80C
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Percutaneous intradiscal radiofrequency thermocoagulation for 360 seconds at 80C
Number of subjects: 39
Study: 11732512

Group type: EXPERIMENTAL
Intervention: Automatic feedback control system
Number of subjects: 22

Group type: COMPARATOR
Intervention: Human control (manual method)
Number of subjects: 22
Study: 9039547

Group type: EXPERIMENTAL
Intervention: Rifabutin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Clarithromycin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Prophylaxis against MAC
Number of subjects: 0
Study: 1302472

Group type: EXPERIMENTAL
Intervention: Chemotherapy alternating with radiotherapy (4 cycles of intravenous cisplatin 20 mg/m²/day for 5 days and fluorouracil 200 mg/m²/day for 5 days, alternating with radiotherapy in three 2-week courses of 20 Gy per course, 2 Gy per day, 5 days per week)
Number of subjects: 157

Group type: COMPARATOR
Intervention: Radiotherapy alone (up to 70 Gy; 2 Gy per day, 5 days per week)
Number of subjects: 157

Group type: EXPERIMENTAL
Intervention: Chemotherapy alternating with radiotherapy
Number of subjects: 157

Group type: COMPARATOR
Intervention: Radiotherapy alone
Number of subjects: 157
Study: 4001761

Group type: EXPERIMENTAL
Intervention: Middle meatal antrostomy
Number of subjects: 38

Group type: COMPARATOR
Intervention: Inferior meatal antrostomy
Number of subjects: 38
Study: 29320597

Group type: EXPERIMENTAL
Intervention: SPF 70 sunscreen applied at 2 mg/cm2
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: SPF 70 sunscreen applied at 1 mg/cm2
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: SPF 15 sunscreen applied at 2 mg/cm2
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: SPF 15 sunscreen applied at 1 mg/cm2
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Both dose study groups (SPF 15 and 70)
Number of subjects: 24
Study: 27497456

Group type: EXPERIMENTAL
Intervention: Patient-centered web-based/digital Breaking Bad News communication training module
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Other similarly designed modules (Living Through Treatment, Transitions, Spirituality, Family)
Number of subjects: 0
Study: 23954085

Group type: EXPERIMENTAL
Intervention: Prostate-specific antigen (PSA) testing offered at 4-year intervals
Number of subjects: 34833

Group type: EXPERIMENTAL
Intervention: Prostate-specific antigen (PSA) testing after correction for nonattendance and contamination
Number of subjects: 34833

Group type: COMPARATOR
Intervention: Screening (PSA testing)
Number of subjects: 34833
Study: 23008825

Group type: EXPERIMENTAL
Intervention: 2x8 Gy preoperative intracavitary HDR BT followed by radical surgery
Number of subjects: 100

Group type: COMPARATOR
Intervention: No preoperative treatment before planned radical Wertheim hysterectomy
Number of subjects: 100
Study: 20353496

Group type: EXPERIMENTAL
Intervention: Active treatment (proton pump inhibitors or H(2)-receptor antagonists)
Number of subjects: 9989

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9989

Group type: COMPARATOR
Intervention: PPI therapy
Number of subjects: 9989
Study: 18671147

Group type: EXPERIMENTAL
Intervention: Albuterol Sulfate (90 micrograms/puff)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Albuterol/Ipratropium bromide (90 micrograms/puff/18 micrograms/puff)
Number of subjects: 20
Study: 15832349

Group type: EXPERIMENTAL
Intervention: Claw foot (CFS)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Normal foot (NFS)
Number of subjects: 72
Study: 12410709

Group type: EXPERIMENTAL
Intervention: Twice weekly NB-UVB phototherapy (Monday and Friday)
Number of subjects: 113

Group type: COMPARATOR
Intervention: Three times weekly NB-UVB phototherapy (Monday, Wednesday and Friday)
Number of subjects: 113
Study: 9864001

Group type: EXPERIMENTAL
Intervention: Budesonide (800 microg twice daily by Turbohaler)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 7618771

Group type: EXPERIMENTAL
Intervention: Plain lidocaine
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Buffered lidocaine
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Warm lidocaine
Number of subjects: 45

Group type: COMPARATOR
Intervention: Need for additional anesthesia
Number of subjects: 45

Group type: COMPARATOR
Intervention: Pain on suturing
Number of subjects: 45
Study: 2224060

Group type: EXPERIMENTAL
Intervention: Bestatin (30 mg/bw per os daily)
Number of subjects: 101

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 101
Study: 12262389

Group type: EXPERIMENTAL
Intervention: Combination of Depo-Provera and Depo-Testosterone
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cessation of drug administration
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Drug administration
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Maintenance doses of the drug
Number of subjects: 0
Study: 31640791

Group type: EXPERIMENTAL
Intervention: VFC (vibrotactile feedback)
Number of subjects: 141

Group type: EXPERIMENTAL
Intervention: VFC+ (vibrotactile feedback + web portal)
Number of subjects: 141

Group type: EXPERIMENTAL
Intervention: VFC and VFC+
Number of subjects: 141

Group type: COMPARATOR
Intervention: NFC (no feedback)
Number of subjects: 141
Study: 29325884

Group type: EXPERIMENTAL
Intervention: Experimental pain (unilateral and bilateral) in R‐LBP patients
Number of subjects: 53

Group type: COMPARATOR
Intervention: Experimental pain (unilateral and bilateral) in healthy controls
Number of subjects: 53

Group type: COMPARATOR
Intervention: Experimental pain (bilateral)
Number of subjects: 53
Study: 26862813

Group type: EXPERIMENTAL
Intervention: Fluoxetine
Number of subjects: 530

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 530
Study: 26213503

Group type: EXPERIMENTAL
Intervention: Educational materials targeted to health literacy levels and learning styles
Number of subjects: 160

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 160
Study: 23954165

Group type: EXPERIMENTAL
Intervention: Carotid artery stenting (CAS)
Number of subjects: 224

Group type: COMPARATOR
Intervention: Carotid endarterectomy (CEA)
Number of subjects: 224
Study: 20807462

Group type: EXPERIMENTAL
Intervention: 1% (w/v) Longjing green tea
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: 1% (w/v) screw-shaped green tea
Number of subjects: 18

Group type: COMPARATOR
Intervention: Water (control)
Number of subjects: 18
Study: 18215746

Group type: EXPERIMENTAL
Intervention: Oscillating-Energy Manual Therapy (OEMT) for six sessions
Number of subjects: 23

Group type: COMPARATOR
Intervention: Placebo treatment (oscillating energy directed to an area above or below the tender points)
Number of subjects: 23
Study: 16774103

Group type: EXPERIMENTAL
Intervention: Interferon-alpha
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Interferon-gamma
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Interleukin-2
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Interleukin-10
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Granulocyte-macrophage colony-stimulating factor
Number of subjects: 0
Study: 14728888

Group type: EXPERIMENTAL
Intervention: Methylprednisolone pulse therapy (MPT) intravenously (30 mg/kg) for 3 days followed by oral prednisone
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Methylprednisolone pulse therapy (MPT)
Number of subjects: 30
Study: 10859047

Group type: EXPERIMENTAL
Intervention: Topical treatment with fibrin-stabilising factor XIII
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 9174312

Group type: EXPERIMENTAL
Intervention: Intraarticular morphine (1 mg)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Intraarticular saline
Number of subjects: 23

Group type: COMPARATOR
Intervention: Intravenous morphine
Number of subjects: 23

Group type: COMPARATOR
Intervention: Intravenous saline
Number of subjects: 23
Study: 8457047

Group type: EXPERIMENTAL
Intervention: Hypothermic group (temperature < 35 degrees C)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Normothermic group (temperature >= 35 degrees C)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Hypothermic group
Number of subjects: 100

Group type: COMPARATOR
Intervention: Normothermic group
Number of subjects: 100
Study: 3920301

Group type: EXPERIMENTAL
Intervention: Sodium cromoglycate (SCG), 20 mg, four times a day for 6 weeks
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Sodium cromoglycate (SCG)
Number of subjects: 22
Study: 30243061

Group type: EXPERIMENTAL
Intervention: Single‐shot paravertebral block with 0.2% ropivacaine with 1:200000 adrenaline
Number of subjects: 50
Study: 28833067

Group type: EXPERIMENTAL
Intervention: Flexible duty hour policy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard duty hour policy
Number of subjects: 0
Study: 26021213

Group type: EXPERIMENTAL
Intervention: Reflexology
Number of subjects: 90
Study: 25735811

Group type: EXPERIMENTAL
Intervention: Hot‐BITs treatment (Hometreatment brings inpatient‐treatment outside), 12 weeks of intensive support after early discharge.
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (standard inpatient treatment).
Number of subjects: 100
Study: 22228239

Group type: EXPERIMENTAL
Intervention: PAP of 20 cmH2O (group C)
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: PAP of 25 cmH2O (group D)
Number of subjects: 240

Group type: COMPARATOR
Intervention: PAP of 0 cmH2O (group A)
Number of subjects: 240

Group type: COMPARATOR
Intervention: PAP of 15 cmH2O (group B)
Number of subjects: 240
Study: 20381672

Group type: EXPERIMENTAL
Intervention: Supine exercise in Fontan patients
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Diastolic dysfunction in Fontan patients
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Supine exercise with indwelling catheters in Fontan patients
Number of subjects: 29
Study: 18332759

Group type: EXPERIMENTAL
Intervention: Immediate loading with platelet rich plasma (PRP) and 50% autogenous bone combined with substitute graft materials
Number of subjects: 41
Study: 15990457

Group type: EXPERIMENTAL
Intervention: Alpha-helical CRH
Number of subjects: 7
Study: 15526508

Group type: EXPERIMENTAL
Intervention: Carvedilol, 12.5 mg/day for six days
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo for six days
Number of subjects: 50
Study: 11220558

Group type: EXPERIMENTAL
Intervention: DDDR pacing mode
Number of subjects: 78

Group type: COMPARATOR
Intervention: DDD pacing mode
Number of subjects: 78
Study: 7782727

Group type: EXPERIMENTAL
Intervention: Lipid-lowering diet
Number of subjects: 50

Group type: COMPARATOR
Intervention: Normal diet
Number of subjects: 50
Study: 3293257

Group type: EXPERIMENTAL
Intervention: Oral cyclosporine‐A (CyA) 5 mg/kg/day for 6 months
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Oral cyclosporine‐A (CyA) 5 mg/kg/day for an additional 6 months (open trial)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Side effects of CyA
Number of subjects: 20
Study: 31769386

Group type: EXPERIMENTAL
Intervention: Maternal influenza immunization
Number of subjects: 3693

Group type: EXPERIMENTAL
Intervention: Diarrheal illness
Number of subjects: 3693

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 3693
Study: 30575648

Group type: EXPERIMENTAL
Intervention: MitraClip
Number of subjects: 0

Group type: COMPARATOR
Intervention: Medical therapy
Number of subjects: 0
Study: 28412960

Group type: EXPERIMENTAL
Intervention: Thulium laser transurethral vaporesection of the prostate (ThuVARP)
Number of subjects: 410

Group type: COMPARATOR
Intervention: Transurethral resection of the prostate (TURP)
Number of subjects: 410
Study: 25170104

Group type: EXPERIMENTAL
Intervention: Chiron rgp120 with MF59
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: VaxGen rgp120 with aluminum hydroxide (alum)
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: ALVAC-HIV-1/AIDSVAX B/B with alum
Number of subjects: 118

Group type: COMPARATOR
Intervention: Placebo (PACTG 230)
Number of subjects: 118

Group type: COMPARATOR
Intervention: Placebo (PACTG 326)
Number of subjects: 118
Study: 22642697

Group type: EXPERIMENTAL
Intervention: Single 750 mg dose telaprevir with 400 mg ketoconazole
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Multiple doses of telaprevir with 400 mg ketoconazole
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Single 750 mg dose telaprevir with 600 mg rifampicin
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: 750 mg every 8 h telaprevir with 600 mg efavirenz
Number of subjects: 3
Study: 21807759

Group type: EXPERIMENTAL
Intervention: Daclizumab (DAC) high dose with interferon beta (IFNβ)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Daclizumab (DAC) low dose with interferon beta (IFNβ)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Placebo with interferon beta (IFNβ)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Higher DAC dose
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Higher expression of intermediate-affinity IL-2 receptor subunit (CD122) on CD56(bright) NK cells
Number of subjects: 64
Study: 18485139

Group type: EXPERIMENTAL
Intervention: Remineralising toothpaste (Enamelon)
Number of subjects: 57

Group type: COMPARATOR
Intervention: Conventional fluoride dentifrice
Number of subjects: 57
Study: 22269237

Group type: EXPERIMENTAL
Intervention: CEM cement with acid etching
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: CEM cement without acid etching
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: MTA with acid etching
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: MTA without acid etching
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: RMGI with acid etching
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: RMGI without acid etching
Number of subjects: 90

Group type: COMPARATOR
Intervention: MTA and CEM
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: All materials (MTA, CEM, RMGI)
Number of subjects: 90
Study: 16194003

Group type: EXPERIMENTAL
Intervention: IVR-administered Brief Symptom Inventory (BSI)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Paper-and-pencil survey administration
Number of subjects: 0
Study: 12021631

Group type: EXPERIMENTAL
Intervention: AcMPAG in stable phase (3-12 months)
Number of subjects: 38

Group type: COMPARATOR
Intervention: AcMPAG in initial phase (1-3 weeks)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: AcMPAG-AUC(12h)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: AcMPAG concentrations
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: AcMPAG-Alb adducts
Number of subjects: 38
Study: 9739990

Group type: EXPERIMENTAL
Intervention: Night shift (0000-1200 h) for Crew 2 (n = 7) studied in March
Number of subjects: 18

Group type: COMPARATOR
Intervention: Night shift (0000-1200 h) for Crew 1 (n = 11) studied in November
Number of subjects: 18